This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Research Article
Flora Peyvandi
Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy
Corresponding Author
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Declarations:
Declarations
- The author has confirmed that a statement listing potential conflicts of interest or lack thereof is included in the text.
The world is experiencing one of the most severe viral outbreaks in the last years, the pandemic infection by SARS-COV-2, causative agent of COVID-19 disease. The virus reached over 120 countries, with a total number of 6.5 million infected, and 320000 deaths. A deeper understanding of its genomic diversity is mandatory.
We analyzed 21296 SARS-COV-2 reported sequences, defining the existence of recurrent haplotypes and their specific geographical distribution.
Keywords
SARS-COV-2, genetic variants, haplotypes
Figure 1
This is a list of supplementary files associated with this preprint. Click to download.
- Supplementaryinfo.docx
Supplementary information
- SupplementaryTable1datasetsarscov2sequencesinformations.xlsx
Supplementary Table S1
- SupplementaryFigures.pdf
Supplementary Figures
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 1
Posted 02 Aug, 2020
No community comments so far
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Molecular Genetics
Learn more about our company.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Research Article
Flora Peyvandi
Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy
Corresponding Author
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 1
Posted 02 Aug, 2020
No community comments so far
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Molecular Genetics
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Declarations:
Declarations
- The author has confirmed that a statement listing potential conflicts of interest or lack thereof is included in the text.
The world is experiencing one of the most severe viral outbreaks in the last years, the pandemic infection by SARS-COV-2, causative agent of COVID-19 disease. The virus reached over 120 countries, with a total number of 6.5 million infected, and 320000 deaths. A deeper understanding of its genomic diversity is mandatory.
We analyzed 21296 SARS-COV-2 reported sequences, defining the existence of recurrent haplotypes and their specific geographical distribution.
Figure 1
This is a list of supplementary files associated with this preprint. Click to download.
- Supplementaryinfo.docx
Supplementary information
- SupplementaryTable1datasetsarscov2sequencesinformations.xlsx
Supplementary Table S1
- SupplementaryFigures.pdf
Supplementary Figures
Loading...